Principal Financial Group’s Seaport Therapeutics SPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.61M Sell
377,391
-37,281
-9% -$828K ﹤0.01% 1519
2026
Q2
$9.01M Buy
+414,672
New +$7.3M ﹤0.01% 1460

Other funds holding SPTX

Principal Financial Group's SPTX Position: Q3 2026 in Review

Principal Financial Group reduced its Seaport Therapeutics (SPTX) stake by 9% in Q3 2026, selling an estimated $828K and leaving 377,391 shares worth $7.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

Principal Financial Group first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.01M in Q2 2026. 69 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

  • Principal Financial Group held 377,391 shares of Seaport Therapeutics worth $7.61M as of Q3 2026.
  • Principal Financial Group sold 37,281 Seaport Therapeutics shares in Q3 2026, an estimated $828K.
  • Seaport Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #1519 holding.
  • Principal Financial Group first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Principal Financial Group's Seaport Therapeutics position peaked at $9.01M in Q2 2026.
  • 69 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.